Unprecedented 4/7 Bicyclic Carbon Skeleton Sesquiterpenoids With Anti‐Inflammatory Activities Isolated From the Root of Lindera glauca Authors: Yuqian Tang, Yingming Luo, Chuxing Liang, Zelin Chen, Jingxin He, Yan Zhou, Zhongqiu Liu, Hui Cui Published: 2026 ABSTRACT ABSTRACTSix new sesquiterpenoids glasesquiterpenoids A−F (1−6), together with two known ones, 7 and 8, were coisolated from the root of Lindera glauca. Their structures were elucidated by x‐ray diffraction, quantum chemical calculations, and spectroscopic methods. Glasesquiterpenoid A (1) with an unprecedented 4/7 bicyclic carbon skeleton was the first example reported in the class of sesquiterpenoids. In the bioassays, compounds 6‒8 exhibited good inhibitory activity of NO production with IC50 values of 2.4, 5.5, and 4.0 µM, respectively, comparable to the positive control indomethacin (IC50 = 24.1 µM). Introduction Lindera glauca, a plant of the genus Lindera in the Lauraceae family, mainly grows in the southwestern regions of China and has been used to treat abdominal pain, colitis, contusions, and sprains in Chinese folk medicine [1, 2, 3]. Chemical composition research indicates that the components of L. glauca include terpenoids [4, 5, 6], butyrolactones [7], and alkaloids [3, 8]. Among them, sesquiterpenoids are the components with the highest proportion in L. glauca, and the typical compounds are glaucic acid featuring the 5/7 carbon ring skeleton, costic acid, and rupestonic acid derivatives with a 6/6 carbon ring system [7]. Most importantly, some of them exhibited potential anti‐inflammatory [4, 6, 9] and cytotoxic activities [3, 8], which have promising prospects for medicinal development [10]. In our previous studies, sesterterpenoids [4, 5] and sesquiterpenoids [9] had been isolated from the root of L. glauca. In order to enrich the active compounds for further pharmacological research at the animal level, the chemical components of sesquiterpenoids in L. glauca were investigated again using the PE extract as the target, Which led to the identification and isolation of six new sesquiterpenoids glasesquiterpenoids A−F (1−6), together with two known sesquiterpenoids glaucatotone g (7) [6] and (1β,5β)‐1‐hydroxyguaia‐4(15),11(13)‐dieno‐12,5‐lactone (8) [11]. Besides, compound 6−8 displayed good anti‐inflammatory activity. Herein, details of the isolation, structure elucidation, and bioactivity of these compounds (Figure 1) are described. Structures of compounds 1−8. Glasesquiterpenoid A (1) was obtained as a colorless oil. The molecular formula of C15H22O4 was established by (−)‐HRESIMS (Figure S1) at m/z 265.1446 [M − H]− (calcd for C15H21O4, 265.1434), possessing five degrees of unsaturation. From the 1H NMR spectrum (Figure S2), the presence of signals for two methyls (δ H 0.99, d, J = 6.2 Hz, H3‐14; δ H 2.24, s, H3‐15), one sp2 terminal methylene (δ H 5.74, s, Ha‐13; δ H 6.38, s, Hb‐13), four sp3 methines (δ H 1.61, m, H‐1; δ H 2.75, m, H‐3; δ H 2.73, m, H‐7; δ H 1.91, m, H‐10), and four sp3 methylenes (δ H 1.61, m, Ha‐2; δ H 1.86, m, Hb‐2;δ H 1.70, m, H2‐6; δ H 1.81, m, Ha‐8; δ H 1.68, m, Hb‐8; δ H 1.85, m, Ha‐9; δ H 1.37, m, Hb‐9) were observed. The 13C NMR and HSQC data (Figures S3 and S5) showed 15 carbons, including four sp3 methylenes, one sp2 methylene, two carbonyls, two methyls, four sp3 methines, one sp3 quarternary, and one sp2 quaternary carbon (Table S1). The NMR data (Table S1) of 1 were similar to our previously reported sesquiterpenoid glaucic acid [7, 12], they shared the same seven‐membered carbon ring (B ring), however the main differences in 1 were the presence of a unique and rare four‐membered carbon ring (A ring) that fused B ring by the linkage of C‐1 and C‐5, which could be established by the HMBC correlations from H3‐15 to C‐3 and C‐4, from H‐1 to C‐5, from H2‐6 to C‐5 (Figure S6), together with the spin‐system H‐3/H2‐2/H‐1 from the COSY spectrum (Figure S4). Then, the planar structure of 1 was determined by the 2D NMR data as shown in Figure 2. The relative configuration of 1 was investigated by the NOESY experiment, and the NOE correlations from H3‐14 to H3‐15 indicated that they were β‐oriented (Figures 3 and S7). Meanwhile, the NOE correlations from H‐10 to H‐3 and H‐7, from H‐1 to H‐3 and H‐7, indicated that they were α‐oriented. Meanwhile, the absolute configuration of 1 (1S, 3S, 5S, 7R, 10S) was determined by comparison of calculated ECD curves with the experimental ones (Figure 4). Besides, the 13C NMR calculations of two possible conformers of 1a (1S, 3S, 5S, 7R, 10S‐1) and 1b (1S, 3S, 5R, 7R, 10S‐1) were carried out using the Gauge Independent Atomic Orbital (GIAO) technique at the mPW1PW91‐SCRF/6‐311+G (d,p) level of theory in the PCM solvent continuum model with chloroform as a solvent. The experimental and calculated data were compared by the improved probability DP4+ method, and the results showed that 1a (Supporting Information, 1S, 3S, 5S, 7R, 10S‐1 = Isomer1) was a reasonable structure with a high DP4+ probability score at 100%. Finally, the absolute configuration of 1 was unambiguously defined as 1S, 3S, 5S, 7R, 10S‐1. To the best of our knowledge, this is the first report of a sesquiterpene possessing a fused 4/7 bicyclic carbon skeleton [13]. Key HMBC (blue arrows) and 1H‐1H COSY (red bold) correlations of compound 1−6. Key NOESY correlations of compound 1−6. Experimental and calculated ECD spectra of compounds 1, 3, 4, and 6 in methanol. Glasesquiterpenoid B (2) was isolated as colorless crystals. Its molecular formula C14H18O3 was determined based on the (−)‐HRESIMS (Figure S8) data m/z 233.1183 [M − H]− (calcd for C14H17O3, 233.1177). The 1D and 2D NMR data of 2 (Table S1 and Figures S9–S14) were similar to those of glaucic acid [7, 12], except that a carbonyl group replaced the methyl group at C‐4 in 2. This deduction was further supported by the HMBC correlations from H‐6 to C‐4 and C‐5, and from H‐3 to C‐4 (Figure S13). Further 2D NMR data established the complete structure of 2 as shown in Figure 2. H‐7 and H‐10 are α‐oriented, as evidenced by the NOE correlation between them. (Figures 3 and S14). Finally, the complete structure and the absolute configuration of 2 were confirmed by the x‐ray diffraction data (Figure 5) with a Flack parameter of 0.04(6). To the best of our knowledge, this is a rare 4‐demethyl‐sesquiterpenoid. X‐ray crystallographic analyses of compounds 2, 3, 4, and 5 (displacement ellipsoids are drawn at the 30% probability level). Glasesquiterpenoid C (3) had a molecular formula of C15H20O4, as established by the (−)‐HRESIMS (Figure S15) at m/z 263.1284 [M − H]− (calcd for C15H19O4, 263.1277). A total of 15 carbons were obtained in the 13C NMR spectrum (Figure S17), which was further characterized as two methyls, four sp3 methylenes, one sp2 terminal methylene, three methines, and five quaternary carbons. The above NMR characteristics of 3 (Table S1, and Figures S16 and S17) were similar to those of glaucic acid [7, 12], except that an additional carbonyl at C‐2 was presented in 3, and the double bond at C‐1 and C‐5 in glaucic acid was replaced by one epoxy ring in 3, which was supported by the HMBC from H‐3 to C‐2, from H‐6 to C‐5, from H3‐15 to C‐5, and from H3‐14 to C‐1 (Figure S20), together with the spin‐systems of H2‐3/H‐4/H3‐15, H2‐6/H‐7/H2‐8/H2‐9/H‐10/H3‐14 from the 1H‐1H COSY spectrum (Figure S18) and HSQC data (Figure S19). The NOE correlations from H3‐14 to H3‐15 assigned these protons as β‐orientation, and the α‐oriented protons of H‐7 and H‐10 were evidenced by the NOE correlation from H‐7 to H‐10 (Figures 3 and S21). Finally, the complete structure and the absolute configuration of 3 were confirmed by the x‐ray diffraction data (Figure 5) with a Flack parameter of −0.01(12). A molecular formula of C15H22O4 for glasesquiterpenoid D (4) was determined by the (−)‐HRESIMS (Figure S22) m/z 265.1443 [M − H]− (calcd for C15H21O4 265.1434). The 1D NMR data of 4 (Table S2 and Figures S23 and S24) showed 15 carbon resonances comprising 2 methyls, 5 sp3 methylenes, 2 sp3 methines, 1 terminal sp2 methylene, and 5 quaternary carbons. The NMR data of 4 were very similar to those of 3, except for the absence of a carbonyl group at C‐2 and the presence of an oxygenated quaternary carbon at C‐4. This assignment was further confirmed by the HMBC correlations (Figure S27), as shown in Figure 2, together with HSQC and 1H‐1H COSY data (Figures S25 and S26). The NOE correlations (Figure 3 and S28) between H3‐14 and H3‐15 were observed, demonstrating that H3‐14 and H3‐15 were close together in space and were in the same orientation. Finally, the absolute configuration of 4 was established by x‐ray diffraction (Figure 5) with Flack parameter −1.0(8) together with the ECD calculations as shown in Figure 4. Glasesquiterpenoid E (5) was obtained as colorless crystals, which were determined as C15H22O4 based on the (−)‐HRESIMS (Figure S29) at m/z 265.1443 [M − H]− (calcd for C15H21O4, 265.1434), accounting for five degrees of unsaturation. In the 1H NMR spectrum (Figure S30), the NMR data were similar to those of 4. Interpretation of the 13C NMR and HSQC data (Table S2, and Figures S31 and S33) revealed that a total of 15 carbon signals were observed, corresponding to 2 sp2 quaternary carbons (including a carboxyl), 1 terminal methylene, 4 sp3 methylenes, 4 sp3 methines (including one oxygenated), 2 non‐protonated carbons, and 2 methyls. Besides, a 1,2‐epoxy ring and a hydroxyl substitution at the C‐5 position in 5 were determined by the HMBC correlations from H3‐14 and H2‐6 to C‐1, from H3‐15 and H2‐6 to C‐5. In addition, further HMBC correlations (Figures 2 and S34) and 1H‐1H COSY data (Figure S32) confirmed the planar structure. The NOE correlations from H3‐14 to H3‐15 in the NOESY spectrum inferred that H3‐14/H3‐15 were β‐oriented. On the contrary, the NOE correlations from H‐2 to H‐4 and H‐10, from H‐7 to H‐10, indicated that these protons were α‐oriented (Figures 3 and S35). Finally, a single‐crystal x‐ray diffraction experiment using Cu Kα radiation (Figure 5) with a Flack parameter [0.09(5)] confirmed the absolute configuration of 5. Glasesquiterpenoid F (6) was isolated as a pale yellowish oil. Its molecular formula was assigned as C15H20O3 on the basis of (+)‐HRESIMS (Figure S36) m/z 271.1299 [M + Na]+ (calcd for C15H20O3Na, 271.1304), corresponding to six degrees of unsaturation. The 1H and 13C NMR data of 6 (Table S2 and Figures S37 and 38) were similar to those of β‒costic acid [14], belonging to the eudesmane‐type sesquiterpene. A carbonyl group located at C‐2 was established by the HMBC correlations from H3‐14 to C‐1 and C‐2, and the six‐membered lactone ring was confirmed by the HMBC correlations from H2‐13 to C‐11, C‐12, and C‐8, from H2‐7 to C‐6 and C‐11 (Figure S41), together with HRESIMS data. Moreover, further 2D NMR data (Figures 2 and S39‐S41) determined the planar structure of 6. The protons of H3‐14 and H3‐15 were assigned as β‐oriented protons, evidenced by the NOE correlation from H3‐14 to H3‐15, and the α‐oriented protons of H‐5 and H‐8 were established by the NOE correlation from H‐7 to H‐5 and H‐8 (Figure 3 and S42). Finally, the absolute configuration of 6 was determined by comparison of calculated ECD curves with the experimental ones (Figure 4). To the best of our knowledge, glasesquiterpenoid A with a rare 4/7 bicyclic carbon skeleton is the first example in the sesquiterpene family. The plausible biogenetic pathway of 1 was proposed as shown in Figure 6. Glaucic acid, the main component in this plant, was deemed the original unit. The key intermediate was generated from the glaucic acid, subsequently forming the intermediate ii by radical reaction. Finally, compound 1 could be constructed by means of oxidation and reduction reactions. In the bioassay, all the isolates were screened for their nitric oxide (NO) release inhibitory activity at 25.0 µM in RAW 264.7 cells. As shown in Table 1, only compounds 6−8 showed stronger inhibitory activity of NO production with IC50 values of 2.4, 5.5, and 4.0 µM, respectively, than the positive control indomethacin (IC50 = 24.1 µM). Meanwhile, compounds 6−8 did not show obvious cytotoxic activity at a concentration of 50.0 µM. Plausible biogenetic pathway of compound 1. TABLE 1The inhibitory activities of compounds 2−4 and 6−8 against LPS‐stimulated NO production in RAW 264.7 cell, their cytotoxic effects in the presence of LPS were also assessed. Data are presented as the mean ± SEM, n = 3.CompoundNO production inhibition rate (%) in 25.0 µMIC50 (µM)CC50 (µM) 2 15.5 ± 2.0—— 3 4.2 ± 0.6—— 4 6.5 ± 3.2—— 6 92.6 ± 1.22.4 ± 0.1> 50 7 85.2 ± 0.85.5 ± 0.1> 50 8 97.6 ± 3.34.0 ± 0.4> 50Indomethacin—24.1 ± 2.1> 50John Wiley & Sons, Ltd. The inhibitory activities of compounds 2−4 and 6−8 against LPS‐stimulated NO production in RAW 264.7 cell, their cytotoxic effects in the presence of LPS were also assessed. Data are presented as the mean ± SEM, n = 3. Conclusions In summary, six new sesquiterpenoids glasesquiterpenoids A−F (1−6), together with two known ones, 7 and 8, were isolated and identified from the root of L. glauca. Glasesquiterpenoid A was the first example of a sesquiterpene with a rare 4/7 bicyclic carbon skeleton in the sesquiterpene family. Moreover, 6−8 showed good inhibitory effects against nitric oxide production in LPS‐induced RAW 264.7 cells. These findings provided new anti‐inflammatory lead compounds for chemists and pharmacologists. Experimental Section General Experimental Procedures Spectroscopic data were obtained as follows: HRESIMS on an AB Sciex Triple‑TOF 5600+, NMR (1H 400 MHz, 13C 100 MHz, 2D) on a Bruker AVANCE‑400 (Bruker BioSpin Corporation, Billerica, MA, USA) with TMS as reference, IR (KBr discs) on a Nicolet 5DX‑FTIR (Thermo Fisher Scientific, Inc., Hudson, NH, USA), and UV on a Shimadzu UV‑240. Optical rotation and ECD were measured at 25°C on a Bellingham‑Stanley ADP 440+ and an Applied Photophysics Chirascan, respectively. Column chromatography employed silica gel (200–300 mesh, Marine Chemical Ltd., Qingdao, China) and Sephadex LH‑20 (GE Healthcare Bio‐Sciences AB, Stockholm, Sweden), whereas preparative HPLC utilized a Shimadzu LC‑20AT system equipped with a YMC‑Pack ODS‑A column (10 × 250 mm, 5 µm, Japan). Plant Material The root material of Lindera glauca was collected in August 2023 from Enshi Tujia and Miao Autonomous Prefecture, Hubei Province, China. Taxonomic identification was performed by Dr. Guangtian Peng (Guangzhou University of Chinese Medicine), and a voucher specimen (accession No. 2023‐GZU‐8m) has been deposited in the School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine. Extraction and Isolation The air‐dried roots (18 kg) were extracted with methanol at room temperature three times, and then the solvent was evaporated under reduced pressure to yield a crude extract Fr. A (2.1 kg). Subsequently, a portion of Fr. A (260 g) was taken as Fr. B. Then, Fr.B was directly subjected to the silica gel column (800 g, 200–300 mesh, 10.0 × 100 cm) eluting with the solvent system (petroleum ether/ethyl acetate, 50:50, v/v, 100% ethyl acetate, 100% methanol, each 5 L) to give 10 fractions (F1–F10). F1 (12.4 g) was further separated by an ODS C18 column (500 g, 6.0 × 80 cm) with a step gradient of MeOH–H2O (70:30‐90:10, v/v, each 3 L), and five sub‐fractions were obtained (F101‐F105). F104 (1.8 g) was further separated by HPLC (YMC‐Pack ODS‐A, MeOH/H2O = 93/7, flow rate = 10.0 mL/min, 1 = 210 nm) to afford F104‐a (105 mg, t R = 26.3 min), F104‐b (103 mg, t R = 30.2 min) and F104‐c (322 mg, t R = 34.5 min). F104‐a was further purified by HPLC (YMC‐Pack ODS‐A, MeOH/H2O = 94/6, flow rate = 2.0 mL/min, l = 210 nm) to yield 3 (11 mg, t R = 25.4 min) and 6 (8 mg, t R = 28.9 min). F104‐b was further purified by HPLC (YMC‐Pack ODS‐A, MeOH/H2O = 96/4, flow rate = 2.0 mL/min, l = 210 nm) to afford 1 (2 mg, t R = 26.4 min) and 5 (6 mg, t R = 28.6 min). Finally, F104‐c was further purified by HPLC (YMC‐Pack ODS‐A, MeOH/H2O = 95/5, flow rate = 2.0 mL/min, l = 210 nm) to yield 4 (10 mg, t R = 28.4 min) and 2 (15 mg, t R = 29.9 min). F105 (0.3 g) was further purified by HPLC (YMC‐Pack ODS‐A, MeOH/H2O = 96/4, flow rate = 2.0 mL/min, l = 210 nm) to yield 7 (39 mg, t R = 32.5 min) and 8 (45 mg, t R = 36.9 min). Glasesquiterpenoid A (1): yellow oil; [α]D25 −14.7 (c 0.19, MeOH); UV (MeCN) λ max (log ε) 200 (4.9) nm; ECD (MeOH) λ max (Δε) 205 (+42.1), 286 (−12.5), 325 (+2.6) nm; IR (KBr) ν max 3481, 2963, 1700, 1457, 1260, 807, 739 cm−1; 1H and 13C NMR data, see Table S1; MS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.14, Found 265.14; HRMS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.1434; Found 265.1446. Glasesquiterpenoid B (2): colorless crystals; mp 123–124; [α]D25 −29.0 (c 0.11, MeOH); UV (MeCN) λ max (log ε) 200 (4.8) nm; ECD (MeOH) λ max (Δε) 201 (−31.2), 220 (−50.3), 307 (+1.2) nm; IR (KBr) ν max 3443, 2921, 1703, 1456, 1259, 1016 cm−1; 1H and 13C NMR data, see Table S1; MS (ESI) m/z: [M − H]− Calcd for C14H17O3 233.12, Found 233.11; HRMS (ESI) m/z: [M − H]− Calcd for C14H17O3 233.1177; Found 233.1183. Glasesquiterpenoid C (3): colorless crystals; mp 125−126; [α]D25 +20.2 (c 0.09, MeOH); UV (MeCN) λ max (log ε) 200 (4.7) nm; ECD (MeOH) λ max (Δε) 210 (−49.4), 327 (+4.0) nm; IR (KBr) ν max 3416, 2921, 2850, 1695, 1463, 1260, 1093, 1019, 802 cm−1; 1H and 13C NMR data, see Table S1; MS (ESI) m/z: [M − H]− Calcd for C15H19O4 263.13, Found 263.12; HRMS (ESI) m/z: [M − H]− Calcd for C15H19O4 263.1277; Found 263.1284. Glasesquiterpenoid D (4): colorless crystals; mp 125−126; [α]D25 −62.7 (c 0.14, MeOH); UV (MeCN) λ max (log ε) 200 (5.0) nm; ECD (MeOH) λ max (Δε) 203 (−25.9), 211 (+7.2), 251 (−9.0) nm; IR (KBr) ν max 3418, 2925, 1705, 1450, 1260, 1027 cm−1; 1H and 13C NMR data, see Table S2; MS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.13, Found 265.14; HRMS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.1434; Found 265.1443. Glasesquiterpenoid E (5): colorless crystals; mp 145−146; [α]D25 +28.1 (c 0.13, MeOH); UV (MeCN) λ max (log ε) 205 (4.2) nm; IR (KBr) ν max 3447, 2926, 1695, 1625, 1381, 1267, 1159, 1085, 989, 897, 830, 735 cm−1; 1H and 13C NMR data, see Table S2; MS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.14, Found 265.14; HRMS (ESI) m/z: [M − H]− Calcd for C15H21O4 265.1434; Found 265.1443. Glasesquiterpenoid F (6): yellow oil; [α]D25 −74.2 (c 0.06, MeOH); UV (MeCN) λ max (log ε) 200 (4.8) nm; ECD (MeOH) λ max (Δε) 211 (−48.7), 254 (−9.0), 293 (+23.9), 314 (−12.9) nm; IR (KBr) ν max 3443, 2921, 1703, 1456, 1259, 1016 cm−1; 1H and 13C NMR data, see Table S2; MS (ESI) m/z: [M + Na]+ Calcd for NaC15H20O3 271.13, Found 271.12; HRMS (ESI) m/z: [M + Na]+ Calcd for NaC15H20O3 271.1304; Found 271.1299. X‐Ray Crystallographic Analysis of Compound 2−5 The single‐crystal x‐ray diffraction data were collected for compound 2−5 on an XtaLAB Pro: Kappa single diffractometer with Cu Kα radiation (λ = 1.54184 Å). The structures were solved by direct methods (SHELXS‐97) and refined using full‐matrix least‐squares difference Fourier techniques. Hydrogen atoms bonded to carbons were placed on the geometrically ideal positions by the “ride on” method. Hydrogen atoms bonded to oxygen were located by the difference Fourier method and were included in the calculation of structure factors with isotropic temperature factors. Crystallographic data for compound 2−5 have been deposited with the Cambridge Crystallographic Data Centre (CCDC: 2499570 for 2, 2493380 for 3, 2493381 for 4, 2499571 for 5). Copies of the data can be obtained, free of charge, on application to the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: 44‐(0)1223‐336033, or e‐mail: deposit@ccdc.cam.ac.uk). Crystal Data of 2: C14H18O3 (M = 234.28 g/mol): monoclinic, space group P 21 (no. 4), a = 11.3489(6) Å, b = 9.4834(6) Å, c = 11.7957(7) Å, β = 93.585(3)°, V = 1267.04(13) Å3, Z = 4, T = 303.0 K, μ(CuKα) = 0.689 mm−1, Dcalc = 1.228 g/cm3, 37169 reflections measured (7.51° ≤ 2Θ ≤ 159.274°), 5392 unique (R int = 0.0599, R sigma = 0.0414) which were used in all calculations. The final R 1 was 0.0612 (I > 2σ(I)), and wR 2 was 0.1772 (all data). Flack parameter: 0.04(6). Crystal Data of 3: C15H20O4 (M = 264.31 g/mol): monoclinic, space group P 21 (no. 4), a = 15.3014(6) Å, b = 6.1382(3) Å, c = 15.9312(7) Å, β = 105.733(3)°, V = 1440.25(11) Å3, Z = 4, T = 303.0 K, μ(CuKα) = 0.716 mm−1, Dcalc = 1.219 g/cm3, 41380 reflections measured (5.764° ≤ 2Θ ≤ 159.458°), 6130 unique (R int = 0.1377, Rsigma = 0.1028) which were used in all calculations. The final R 1 was 0.0506 (I > 2σ(I)), and wR 2 was 0.1530 (all data), Flack parameter: −0.01(12). Crystal data of 4: C15H22O4 (M = 266.56 g/mol): triclinic, space group P 1 (no. 1), a = 9.888(2) Å, b = 11.684(3) Å, c = 13.122(5) Å, α = 75.22(2), β = 90°, γ = 90°, V = 1465.9(8) Å3, Z = 4, T = 303.0 K, μ(CuKα) = 0.703 mm−1, Dcalc = 1.199 g/cm3, 26950 reflections measured (7.826° ≤ 2Θ ≤ 157.67°), 9685 unique (R int = 0.6581, R sigma = 0.5479) which were used in all calculations. The final R 1 was 0.1008 (I > 2σ(I)), and wR 2 was 0.4139 (all data). Flack parameter: −1.0(8). Crystal data of 5: C15H22O4 (M = 266.29 g/mol): orthorhombic, space group P 212121 (no. 19), a = 7.31290(10) Å, b = 11.82000(10) Å, c = 16.4331(2) Å, V = 1420.45(3) Å3, Z = 4, T = 293(2) K, μ(Cu Kα) = 0.725 mm−1, Dcalc = 1.227 g/cm3, 12746 reflections measured (9.216° ≤ 2Θ ≤ 136.014°), 2576 unique (R int = 0.0238, R sigma = 0.0144) which were used in all calculations. The final R 1 was 0.0371 (I > 2σ(I)), and wR 2 was 0.1118 (all data). Flack parameter: 0.09(5). Anti‐Inflammatory Assay and Cell Viability Anti‑inflammatory activity was assessed in RAW 264.7 macrophages. The cells were grown in DMEM with 10% FBS and antibiotics (penicillin G 60 U/mL, streptomycin 100 µg/mL) at 37°C in a 5% CO2 humidified atmosphere. Following trypsin‑EDTA harvesting, cells were seeded at 2 × 104 per well in 96‑well plates and left to attach for 24 h. Test samples, prepared as DMSO stock solutions and diluted to < 0.1% DMSO in medium, were added to the wells (200 µL/well) at graded concentrations (0–100 µM) and incubated for 2 h prior to LPS challenge (1 µg/mL, 48 h). Indomethacin was included as a positive control. Nitrite accumulation, an indicator of NO production, was measured in the supernatant via the Griess reaction: 100 µL aliquots were mixed with equal volumes of Griess reagent (0.2% naphthylenediamide dihydrochloride and 2% sulfanilamide in 5% H3PO4), agitated at room temperature, and read at 540 nm using a microplate reader (Bio‑Rad). A standard curve was constructed with sodium nitrite. All assays were run in triplicate. The MTT assay was employed to monitor cell viability. RRID: CVCL_0493. ECD Calculation Methods ECD computations: Monte Carlo searching (MMFF, Spartan 14) was used to explore the conformational space of compounds 1, 4, and 6. Conformers with a Boltzmann weight > 5% were retained, optimized in the gas phase at B3LYP/6‐31 g (d, p), and then subjected to TD‑DFT ECD calculations at B3LYP/6‐31+g(d, p), MeOH, 50 excited states. Rotatory strengths were converted to ECD spectra via SpecDis 1.6 and GraphPad Prism 5, applying Gaussian broadening with sigma = 0.3 eV. NMR calculations: For compound 1, GIAO 13C NMR chemical shifts were computed at the mPWLPW91‐SCRF (CHCl3)/6‐311+g (d, p) level using the PCM model in Gaussian 09. Boltzmann averaging over the lowest‑energy conformers was performed, with TMS as the reference. The experimental and theoretical shifts were compared by the DP4+ probability method, which gave a strongly dominant score for compound 1, thereby confirming its stereochemistry. Author Contributions Zelin Chen: data curation. Chuxing Liang: software, methodology. Jingxin He: investigation. Yuqian Tang: investigation, writing – original draft, conceptualization, methodology, software, data curation, formal analysis, validation, supervision, resources. Zhongqiu Liu: writing – review and editing, funding acquisition, methodology. Yan Zhou: investigation. Hui Cui: writing – review and editing, funding acquisition, methodology, conceptualization, software, project administration, resources, formal analysis, visualization. Yingming Luo: data curation, methodology, software. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supporting File 1: cbdv71663‐sup‐0001‐SuppMat.pdf